Analyst Recommendations

Morgan Stanley analyst issues OVERWEIGHT recommendation for CL on February 2, 2026 11:26AM ET. The previous analyst recommendation was Overweight.CL was trading at $90.29 at issue of the...

February 2, 2026   CL -0.15%

UBS analyst issues NEUTRAL recommendation for TRV on February 2, 2026 11:27AM ET. The previous analyst recommendation was Neutral.TRV was trading at $284.51 at issue of the analyst...

February 2, 2026   TRV -0.32%

UBS analyst issues BUY recommendation for XOM on February 2, 2026 11:36AM ET. The previous analyst recommendation was Buy.XOM was trading at $141.63 at issue of the analyst...

February 2, 2026   XOM 0.95%

Wells Fargo analyst issues OVERWEIGHT recommendation for CHD on February 2, 2026 11:29AM ET. The previous analyst recommendation was Overweight.CHD was trading at $96.25 at issue of the...

February 2, 2026   CHD -0.13%

Piper Sandler analyst issues OVERWEIGHT recommendation for FIBK on February 2, 2026 11:39AM ET. The previous analyst recommendation was Overweight.FIBK was trading at $35.47 at issue of the...

February 2, 2026   FIBK 2.60%

Piper Sandler analyst issues NEUTRAL recommendation for FISI on February 2, 2026 11:41AM ET. The previous analyst recommendation was Neutral.FISI was trading at $32.94 at issue of the...

February 2, 2026   FISI 2.92%

Guggenheim analyst issues BUY recommendation for AVTX on February 2, 2026 11:35AM ET. AVTX was trading at $15.11 at issue of the analyst recommendation.The overall analyst consensus :...

February 2, 2026   AVTX 0.97%

Piper Sandler analyst issues NEUTRAL recommendation for EGBN on February 2, 2026 11:37AM ET. The previous analyst recommendation was Neutral.EGBN was trading at $26.76 at issue of the...

February 2, 2026   EGBN 2.21%

Piper Sandler analyst issues OVERWEIGHT recommendation for HAFC on February 2, 2026 11:33AM ET. The previous analyst recommendation was Overweight.HAFC was trading at $26.57 at issue of the...

February 2, 2026   HAFC 3.99%

Citigroup analyst issues BUY recommendation for ARCB on February 2, 2026 11:45AM ET. The previous analyst recommendation was Buy.ARCB was trading at $90.22 at issue of the analyst...

February 2, 2026   ARCB 5.33%